Literature DB >> 8486219

Fatal herpes simplex hepatitis type 2 in a post-thymectomized adult.

N Takebe1, A Yokoyama, Y Akasaka, H Ishii, S Miyaguchi, T Sata, T Hibi, M Oda, J Hata, M Tsuchiya.   

Abstract

The authors report an unusual case of herpes simplex type 2 (HSV) hepatitis which presented as part of a systemic HSV infection accompanied by disseminated intravascular coagulation (DIC). The patient was a 49-year-old Japanese male who three months prior to admission underwent surgical resection of his thymus for an invasive thymoma. Postoperatively, he received a course of chemotherapy which included prednisone, cyclophosphamide, vincristine, and pinorubicin. After discharge from the hospital, he was put on a maintenance dosage of prednisone and cyclophosphamide. Two weeks prior to this admission, the patient developed rhinorrhea, chills and general fatigue. Routine follow-up laboratory tests revealed markedly elevated liver enzymes which led to his immediate hospitalization. The tentative diagnosis on admission was fulminant hepatitis with DIC. The patient's condition steadily worsened during his hospitalization and acyclovir was initiated on the 4th hospital day due to the possibility of HSV hepatitis. He died on the same day. Histopathology performed on the liver at autopsy revealed hepatic inclusion bodies of HSV with positive immunohistochemical detection of the HSV type 2 antigen. Our case is the first report of HSV hepatitis associated with the removal of the thymus secondary to thymoma. It supports previous observations of disseminated HSV infection being prevalent in those patients with disorders of cell mediated immunity.

Entities:  

Mesh:

Year:  1993        PMID: 8486219     DOI: 10.1007/bf02779235

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  52 in total

Review 1.  Fulminant herpes simplex hepatitis in an adult: report of a case in renal transplant recipient.

Authors:  S Anuras; R Summers
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

2.  Hepatitis in an adult caused by Herpes simplex virus type I.

Authors:  L Eron; K Kosinski; M S Hirsch
Journal:  Gastroenterology       Date:  1976-09       Impact factor: 22.682

3.  Disseminated herpes simplex type 2 and systemic Candida infection in a patient with previous asymptomatic human immunodeficiency virus infection.

Authors:  W Zimmerli; L Bianchi; F Gudat; H Spichtin; P Erb; M von Planta; P U Heitz
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

4.  Lethal herpes simplex virus type 1 hepatitis in a normal adult.

Authors:  R W Connor; G Lorts; D N Gilbert
Journal:  Gastroenterology       Date:  1979-03       Impact factor: 22.682

5.  Non-responsive coeliac disease.

Authors: 
Journal:  Br Med J       Date:  1972-09-09

6.  A case of fulminant herpes simplex hepatitis in an adult.

Authors:  H Lüchtrath; V Totović; F de Leon
Journal:  Pathol Res Pract       Date:  1984-11       Impact factor: 3.250

7.  Disseminated herpes simplex virus infection with hepatitis in an adult renal transplant recipient.

Authors:  D P Walker; M Longson; W Lawler; N P Mallick; J S Davies; R W Johnson
Journal:  J Clin Pathol       Date:  1981-09       Impact factor: 3.411

8.  Herpes simplex virus hepatitis in a renal transplant recipient: successful treatment with acyclovir.

Authors:  H Gäbel; L Flamholc; K Ahlfors
Journal:  Scand J Infect Dis       Date:  1988

9.  Hepatitis due to herpes simplex virus in a nonpregnant patient: treatment with acyclovir.

Authors:  R P Baxter; L E Phillips; S Faro; L Hoffman
Journal:  Sex Transm Dis       Date:  1986 Jul-Sep       Impact factor: 2.830

10.  Non-inflammatory herpes simplex hepatitis in an adult with chronic neutropenia.

Authors:  J Bernuau; B Rueff; J P Clauvel; C Degott; Y Perol; J P Benhamou
Journal:  Liver       Date:  1981-09
View more
  1 in total

1.  Five cases of fulminant hepatitis due to herpes simplex virus in adults.

Authors:  Antonio D Pinna; Jorge Rakela; Anthony J Demetris; John J Fung
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.